Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids
Authors:
- Claude WolfCWClaude Wolf
- Ullah BarbeUBUllah Barbe
- Pedro BauseroPBPedro Bausero
- Francesco VisioliFrancesco Visioli
- 1 February 2013
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 88 (2) , 149-154
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver diseaseClinical Nutrition, 2011
- DHA Metabolism: Targeting the Brain and LipoxygenationMolecular Neurobiology, 2010
- Fatty liver: Role of inflammation and fatty acid nutritionProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2010
- Loss of Stearoyl-CoA Desaturase-1 Attenuates Adipocyte InflammationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathwayBiochemical and Biophysical Research Communications, 2009
- Polyunsaturated fatty acids and cardiovascular diseaseCellular and Molecular Life Sciences, 2009
- Relationship Among Histologic, Radiologic, and Biochemical Assessments of Hepatic SteatosisJournal of Clinical Gastroenterology, 2007
- Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses: biochemical and autoradiographic studiesCanadian Journal of Physiology and Pharmacology, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976